Adjuvant pembrolizumab improves overall survival in patients with RCC

Nature Reviews Clinical Oncology, Published online: 29 April 2024; doi:10.1038/s41571-024-00901-2Adjuvant pembrolizumab improves overall survival in patients with RCC

https://www.nature.com/articles/s41571-024-00901-2

Source: Nature Reviews Clinical Oncology - April 29, 2024 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research

More News: Cancer & Oncology